Two injections of interferon-alpha could trigger the development of rheumatoid arthritis.
Funauchi
M
M
Ohno
M
M
Nozaki
Y
Y
Kinoshita
K
K
Sugiyama
M
M
Kanamaru
A
A
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000473:pathology; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000601:surgery; D003545:Cysteine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D016898:Interferon-alpha; D003545:Cysteine; C026535:bucillamine